Contraceptive Technology Update
RSSArticles
-
Research Examines Self-administered DMPA
New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.
-
Push Is on to Combat Drug-resistant Gonorrhea
In a recently released study, Centers for Disease Control and Prevention (CDC) researchers report that while 81% of patients diagnosed with gonorrhea were treated using dual therapy, nearly one in five were treated with a different regimen.
-
FDA Issues Restrictions for Sterilization Option
The Food and Drug Administration has issued new restrictions regarding the sale and distribution of the permanent contraceptive device, Essure.
-
Check Your Clinical Practice for LARC Methods
The American College of Obstetricians and Gynecologists now recognizes immediate postpartum placement of either the intrauterine device or the contraceptive implant as a best practice because of the long-acting reversible contraceptive methods’ role in preventing rapid repeat and unintended pregnancy
-
Researchers Examine Possible Capsule Option for HIV Drugs
Early research is focusing on a capsule that can deliver a week’s worth of HIV drugs in a single dose. If confirmed in advanced research, such an option could allow patients to stay compliant with the dosing regimen required to fight the virus successfully.
-
Clinical Challenge: PrEP Is Not Reaching Most of the People Who Are at Risk
CDC leads efforts to build PrEP awareness and expand availability.
-
Beyond Efficacy: Applying a Reproductive Justice Framework to Contraceptive Counseling for Young People
A counseling approach that supports bodily autonomy, dignity, and agency of persons works toward ensuring reproductive justice.
-
Research Examines Male Contraception Option
Researchers at the University of Washington and Harbor-University of California, Los Angeles Medical Center are evaluating the use of a daily contraceptive pill containing dimethandrolone undecanoate for men.
-
Study Examines Disparity of Trichomoniasis
Results of a new analysis indicate that trichomoniasis disproportionately affects the black community. Data indicate that while the prevalence of Trichomonas vaginalis infection was 0.03% and 0.8% among males and females of other races/ethnicities, the prevalence was significantly higher among black males and females at 4.2% and 8.9%, respectively.
-
Report: Abortion Safe, but Access to the Procedure May Be Limited
A new report has determined that while abortion in the United States is safe, the quality of abortion care depends on where a woman lives.